CMG190303

· CMG Pharmaceutical Co. Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMG190303, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia [Phase 3]